Our Blog

What if there were 100 people on earth living with cancer?

What if there were 100 people on earth living with cancer? What would that look like?

Read More

Case Study: Marginal gains in late-stage cancer

Our client’s market-leading product had reached a sales plateau after notable growth since launch.

Read More

Bryter case study: Category navigation and path to purchase in consumer health

Adopting a multi-disciplinary approach that goes beyond speaking to patients, to understanding what drives decision making and purchase behaviour for treatments.

Read More

Unpicking biologics Rx decision-making in psoriasis using Multiple-criteria Deci...

MCDA is a highly flexible and powerful analytical approach that unpicks multi-level decision-making.

Read More

Do JAK inhibitors have potential in blood and bone marrow cancers?

Read results from Bryter's JAK inhibitor study - a breakthrough treatment for blood and bone marrow cancers.

Read More

8 in 10 UK oncologists agree that the NHS could fall behind the health systems o...

8 in 10 UK oncologists agree that the NHS could fall behind the health systems of other developed countries

Read More

So, we need stats to test our pipeline drug - but which technique do we use?

So, we need stats to test our pipeline drug - but which technique do we use?

Read More

What doesn’t kill us… can still kill us

What doesn’t kill us… can still kill us

Read More

Internet of [Healthy] Things (IoT) It’s a lot more than clever fridges!

Internet of [Healthy] Things (IoT) It’s a lot more than clever fridges!

Read More

SUBSCRIBE TO OUR BLOG

Bryter is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account .